Please use this identifier to cite or link to this item:
http://elar.urfu.ru/handle/10995/130896
Title: | Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones |
Authors: | Aluru, R. Mukherjee, A. Zyryanov, G. V. Majee, A. Santra, S. |
Issue Date: | 2023 |
Publisher: | Multidisciplinary Digital Publishing Institute (MDPI) |
Citation: | Aluru, R, Mukherjee, A, Zyryanov, G, Majee, A & Santra, S 2023, 'Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones', Current Issues in Molecular Biology, Том. 45, № 10, стр. 8461-8475. https://doi.org/10.3390/cimb45100533 Aluru, R., Mukherjee, A., Zyryanov, G., Majee, A., & Santra, S. (2023). Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones. Current Issues in Molecular Biology, 45(10), 8461-8475. https://doi.org/10.3390/cimb45100533 |
Abstract: | Natural products are a boundless source for the development of pharmaceutical agents against a wide range of human diseases. Accordingly, naturally occurring aurones possess various biological benefits, such as anticancer, antioxidant, antimicrobial, antidiabetic, anti-inflammatory, antiviral and neuroprotective effects. In addition, various studies have revealed that aurones are potential templates for the regulation of diabetes mellitus and its associated complications. Likewise, certain aurones and their analogues have been found to be remarkable kinase inhibitors of DARK2, PPAR-γ, PTPM1, AGE, α-amylase and α-glucosidase, which represents a promising approach for the treatment of chronic metabolic disorders such as diabetes. Therefore, in our present study, we provide a detailed account of the advances in aurones as antidiabetic agents over the past decade. © 2023 by the authors. |
Keywords: | ANTIDIABETIC AURONES CHALCONE FLAVONOIDS Α-GLUCOSIDASE INHIBITOR AMYLASE ANTIDIABETIC AGENT AURONE CHALCONE DERIVATIVE ETHYLENE OXIDE DERIVATIVE FLAVANOID FLAVONE DERIVATIVE GLUCOSIDASE NATURAL PRODUCT PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA UNCLASSIFIED DRUG ANNULATION REACTION ANTIDIABETIC ACTIVITY ANTIINFLAMMATORY ACTIVITY ANTIMICROBIAL ACTIVITY ANTINEOPLASTIC ACTIVITY ANTIOXIDANT ACTIVITY ANTIVIRAL ACTIVITY BIOLOGICAL ACTIVITY BIOSYNTHESIS CYCLIZATION DIABETES MELLITUS DRUG DEVELOPMENT DRUG SYNTHESIS GLUCOSE ABSORPTION GLUCOSE METABOLISM HUMAN HYPERGLYCEMIA IC50 METABOLIC DISORDER NEUROPROTECTION REVIEW SIGNAL TRANSDUCTION |
URI: | http://elar.urfu.ru/handle/10995/130896 |
Access: | info:eu-repo/semantics/openAccess cc-by |
License text: | https://creativecommons.org/licenses/by/4.0/ |
SCOPUS ID: | 85175087801 |
WOS ID: | 001098241800001 |
PURE ID: | 47647488 |
ISSN: | 1467-3037 |
DOI: | 10.3390/cimb45100533 |
metadata.dc.description.sponsorship: | Ministry of Education and Science of the Russian Federation, Minobrnauka This research was funded by the Ministry of Science and Higher Education of the Russian Federation (Ural Federal University Program of Development within the Priority-2030 Program). |
Appears in Collections: | Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2-s2.0-85175087801.pdf | 4,48 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License